26 Jul CHARNWOOD MOLECULAR AND SOLITEK LAUNCH A COLLABORATION COMBINING EXPERTISE IN DRUG DISCOVERY AND DEVELOPMENT
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek. The sector-leading expertise and technology development within Solitek combines an excellent understanding...